Source: Journal of Neuroimmune Pharmacology. Unidades: FCF, FMVZ
Subjects: FÁRMACOS IMUNOSSUPRESSORES, LISTERIA, NEUROIMUNOMODULAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRAZ DE PAULA, Viviane et al. 3,4-methylenedioxymethamphetamine (MDMA – ecstasy) decreases neutrophil activity through the glucocorticoid pathway and impairs host resistance to listeria monocytogenes infection in mice. Journal of Neuroimmune Pharmacology, v. 9, n. 5, p. 690-702, 2014Tradução . . Disponível em: https://doi.org/10.1007/s11481-014-9562-0. Acesso em: 03 nov. 2024.APA
Ferraz de Paula, V., Ribeiro, A., Souza-Queiroz, J., Pinheiro, M. L., Vecina, J. F., Souza, D. P. M., et al. (2014). 3,4-methylenedioxymethamphetamine (MDMA – ecstasy) decreases neutrophil activity through the glucocorticoid pathway and impairs host resistance to listeria monocytogenes infection in mice. Journal of Neuroimmune Pharmacology, 9( 5), 690-702. doi:10.1007/s11481-014-9562-0NLM
Ferraz de Paula V, Ribeiro A, Souza-Queiroz J, Pinheiro ML, Vecina JF, Souza DPM, Quinteiro Filho WM, Moreau RL de M, Queiroz MLS, Palermo-Neto J. 3,4-methylenedioxymethamphetamine (MDMA – ecstasy) decreases neutrophil activity through the glucocorticoid pathway and impairs host resistance to listeria monocytogenes infection in mice [Internet]. Journal of Neuroimmune Pharmacology. 2014 ; 9( 5): 690-702.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/s11481-014-9562-0Vancouver
Ferraz de Paula V, Ribeiro A, Souza-Queiroz J, Pinheiro ML, Vecina JF, Souza DPM, Quinteiro Filho WM, Moreau RL de M, Queiroz MLS, Palermo-Neto J. 3,4-methylenedioxymethamphetamine (MDMA – ecstasy) decreases neutrophil activity through the glucocorticoid pathway and impairs host resistance to listeria monocytogenes infection in mice [Internet]. Journal of Neuroimmune Pharmacology. 2014 ; 9( 5): 690-702.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1007/s11481-014-9562-0
